StonvexLoading…
StonvexStonvexStonvexCore line items from AEHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-30 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $58.97M | $66.22M | $64.96M | $50.83M |
Operating Income | $-5.68M | $10.08M | $13.38M | $7.80M |
Net Income | $-3.91M | $33.16M | $14.56M | $9.45M |
EPS (Diluted) | $-0.13 | $1.12 | $0.50 | $0.34 |
Total Assets | $148.51M | $127.91M | $98.14M | $62.33M |
Total Liabilities | $25.64M | $16.32M | $22.54M | $11.34M |
Cash & Equivalents | $24.53M | $49.16M | $30.05M | $31.48M |
Free Cash Flow OCF − CapEx | $-12.39M | $1.01M | $8.65M | $1.09M |
Shares Outstanding | 29.88M | 29.00M | 28.54M | 27.12M |